CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering

IPO/OfferingPositive
AI Analysis

Summary

ADARx Pharmaceuticals announced the pricing of an upsized initial public offering of $446.3 million. The company completed its IPO pricing, indicating successful market reception for the offering.

Importance:7/10
Sentiment:
0.60
IPOcapital_raiseupsized_offering

Read the original article

Published by GlobeNewswire Pharma on September 24, 2026 11:33 PM

Read Original